|
US2134714A
(en)
|
1936-11-25 |
1938-11-01 |
Jacob A Glassman |
Saccharine-aspirin tablet
|
|
US3622677A
(en)
|
1969-07-07 |
1971-11-23 |
Staley Mfg Co A E |
Compressed tablets containing compacted starch as binder-disintegrant ingredient
|
|
DE19806186A1
(de)
|
1997-02-03 |
1998-11-26 |
Max Delbrueck Centrum |
Genomische Sequenz des humanen mu-Opioid-Rezeptor Genes sowie seiner Varianten, Polymorphismen und Mutationen
|
|
EP1021177A4
(en)
|
1997-02-04 |
2002-05-15 |
John V Kosbab |
COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF VASCULAR DEGENERATIVE DISEASES
|
|
US20050085498A1
(en)
|
1998-05-28 |
2005-04-21 |
Byrd Edward A. |
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
|
|
US6376549B1
(en)
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
|
US20030159178A1
(en)
|
2000-02-10 |
2003-08-21 |
Peter Ulvskov |
Method for remodelling cell wall polysaccharide structures in plants
|
|
US7590493B2
(en)
|
2000-07-31 |
2009-09-15 |
Ocimum Biosolutions, Inc. |
Methods for determining hepatotoxins
|
|
DE10045059A1
(de)
|
2000-09-12 |
2002-03-21 |
Basf Ag |
Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen
|
|
JPWO2002032905A1
(ja)
|
2000-10-20 |
2004-02-26 |
味の素株式会社 |
マラリア治療のための医薬組成物、ドーズおよび方法
|
|
AU2002344820B2
(en)
|
2001-06-20 |
2006-12-14 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
GB0117767D0
(en)
|
2001-07-20 |
2001-09-12 |
Unilever Plc |
Polymers and their synthesis
|
|
US20050031651A1
(en)
*
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
US20050180962A1
(en)
|
2003-01-30 |
2005-08-18 |
Eyal Raz |
Inactivated probiotic bacteria and methods of use thereof
|
|
US20050214413A1
(en)
|
2003-08-26 |
2005-09-29 |
Mannatech, Inc. |
Methods and compositions for modified release of nutritional supplements
|
|
US20050053664A1
(en)
|
2003-09-08 |
2005-03-10 |
Eliezer Zomer |
Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
|
|
GB0421639D0
(en)
*
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
JP3998695B2
(ja)
|
2005-04-22 |
2007-10-31 |
株式会社シクロケム |
αリポ酸水溶液及びその製造方法
|
|
DE112005001269T5
(de)
|
2005-04-26 |
2008-05-29 |
Versitech Ltd. |
Polysaccharidextrakt aus Lycium barbarum als neuroprotektives Mittel gegen ß-Amyloidpeptidneurotoxizität
|
|
US7560536B2
(en)
|
2005-05-18 |
2009-07-14 |
Virginia Tech Intellectual Properties, Inc. |
Morning glory-derived anticancer agents, and novel ipomoeassin compounds
|
|
JP4863204B2
(ja)
|
2005-06-15 |
2012-01-25 |
独立行政法人産業技術総合研究所 |
腎症関連疾患の診断方法及び診断キット
|
|
JP5247012B2
(ja)
|
2006-07-25 |
2013-07-24 |
雪印メグミルク株式会社 |
脂肪肝抑制剤
|
|
EP2106449B1
(en)
|
2007-01-18 |
2012-09-19 |
Novozymes A/S |
Method for producing potato products
|
|
JP2009007309A
(ja)
|
2007-06-29 |
2009-01-15 |
Riken Vitamin Co Ltd |
α−リポ酸含有多芯型マイクロカプセル
|
|
KR101121543B1
(ko)
*
|
2007-07-04 |
2012-03-06 |
학교법인 선목학원 |
벼과식물로부터 수득되는 전분 또는 식이섬유를 포함하는허혈성 질환 및 퇴행성 뇌질환의 예방 및 치료를 위한조성물
|
|
US8569262B2
(en)
*
|
2007-11-02 |
2013-10-29 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
|
AU2010300391A1
(en)
|
2009-10-02 |
2012-04-26 |
University Of Idaho |
Potato products with enhanced resistant starch content and moderated glycemic response and methods thereof
|
|
KR101093413B1
(ko)
|
2009-10-05 |
2011-12-14 |
고려대학교 산학협력단 |
뇌 신경 세포 보호 활성을 갖는 고구마 추출물 및 그의 용도
|
|
EP2510014A1
(en)
|
2009-12-11 |
2012-10-17 |
Unilever NV |
Polysaccharide suitable to modulate immune response
|
|
WO2012016050A2
(en)
|
2010-07-28 |
2012-02-02 |
The General Hospital Corporation |
Chemoradiotherapy for kras-mutant colorectal cancer
|
|
JP2012149004A
(ja)
*
|
2011-01-18 |
2012-08-09 |
Theravalues Corp |
核内受容体の賦活剤
|
|
CA2848711C
(en)
|
2011-09-16 |
2019-08-06 |
Galectin Therapeutics, Inc. |
Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
|
|
AU2013240229B2
(en)
|
2012-03-28 |
2017-07-06 |
The Research Foundation For The State University Of New York |
Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
|
|
US9814255B2
(en)
*
|
2012-05-20 |
2017-11-14 |
Darco Natural Products Inc. |
Method for producing purple sweet potato juice and dried powder
|
|
US9180212B2
(en)
*
|
2012-05-22 |
2015-11-10 |
The Regents Of The University Of California |
β-amyloid plaque imaging agents
|
|
WO2014051076A1
(ja)
|
2012-09-28 |
2014-04-03 |
株式会社Ｂｎａ |
Ｂｎａクランプ法
|
|
GB201223365D0
(en)
|
2012-12-24 |
2013-02-06 |
Provexis Natural Products Ltd |
Compositions
|
|
CN103110657A
(zh)
*
|
2013-01-31 |
2013-05-22 |
黄仁彬 |
玉郎伞多糖在制备药物中的应用
|
|
CN105377271A
(zh)
|
2013-03-15 |
2016-03-02 |
全技术公司 |
含硒组合物及其治疗和预防与线粒体功能障碍有关的疾病或病症的应用
|
|
WO2014200969A2
(en)
|
2013-06-10 |
2014-12-18 |
Millennium Pharmaceuticals, Inc. |
Methods of treatment of cancer
|
|
CA2924597A1
(en)
|
2013-09-19 |
2015-03-26 |
The Research Foundation For The State University Of New York |
Methods and materials for treating diabetes or liver steatosis
|
|
MX2016011897A
(es)
|
2014-03-14 |
2017-04-27 |
Alltech Inc |
Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
|
|
JP6793180B2
(ja)
|
2015-03-27 |
2020-12-02 |
ザ リサーチ ファウンデーション フォー ザ ステイト ユニバーシティ オブ ニューヨーク |
癌を治療するための方法および物質
|
|
US10639322B2
(en)
|
2015-03-27 |
2020-05-05 |
The Research Foundation For The State University Of New York |
Methods and materials for reducing amyloid beta levels within a mammal
|
|
AU2017234662A1
(en)
|
2016-03-14 |
2018-10-04 |
Mitogenetics, Llc |
Materials and methods for treating hypoxic conditions
|